Were Hedge Funds Right About Souring On Karyopharm Therapeutics Inc (KPTI)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Posts Tagged ‘NASDAQ:KPTI’
Karyopharm Therapeutics Inc (KPTI): Hedge Funds Taking Some Chips Off The Table
In this article you are going to find out whether hedge funds think Karyopharm Therapeutics Inc (NASDAQ:KPTI) is a good investment right now. We like...
Were Hedge Funds Right About Karyopharm Therapeutics Inc (KPTI)?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
Hedge Funds Dropped The Ball On Karyopharm Therapeutics Inc (KPTI)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook...
Did Hedge Funds Drop The Ball On Karyopharm Therapeutics Inc (KPTI)?
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions...
Here’s What Hedge Funds Think About Karyopharm Therapeutics Inc (KPTI)
A market surge in the first quarter, spurred by easing global macroeconomic concerns and Powell’s pivot ended up having a positive impact on the...
Here’s What Hedge Funds Think About Karyopharm Therapeutics Inc (KPTI)
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon...
Karyopharm Therapeutics Inc (KPTI) Hedge Funds Are Snapping Up
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse...
Hedge Fund and Insider Trading News: Ray Dalio, Dan Loeb, Edward Lampert, Select Interior Concepts (SIC), American Financial Group Inc (AFG), Air T, Inc. (AIRT), and More
Billionaire Ray Dalio: This is the ‘Biggest Mistake’ that Most Investors Make (CNBC) For new investors, approaching the stock market can be...
Hedge Fund and Insider Trading News: Ray Dalio, Israel Englander, Heartland Express, Inc. (HTLD), Tandy Leather Factory, Inc. (TLF), Solaredge Technologies Inc (SEDG), and More
Ray Dalio Said Last Year Gold was Good Protection because of Trump and North Korea ‘Playing Chicken’ (CNBC) President Donald Trump’s...
13G Filing: Point72 Asset Management and Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (NASDAQ:KPTI): Steve Cohen’s Point72 Asset Management filed an amended 13D. You can check out Point72 Asset Management...
Opus Point Partners’ AUM, History and Investments
Opus Point Partners was founded by Michael S. Weiss and Dr. Lindsay A. Rosenwald in 2009. Prior to launching Opus Point Partners, Mr. Weiss and Dr. Rosenwald...
13D Filing: Delphi Ventures VIII LP and Karyopharm Therapeutics Inc. (KPTI)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing CUSIP NO. 48576U106 13D Page 1 of...
Here’s What Happened To Karyopharm Therapeutics Inc (KPTI) And PTC Therapeutics, Inc. (PTCT)
The end of the week is upon us, and it’s been a bit of a wild ride in the biotech space. Macro forces have come into play from an industry wide sentiment...
Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers...
Looking Ahead To The Karyopharm Therapeutics Inc (KPTI) MM Data
Karyopharm Therapeutics Inc (NASDAQ:KPTI) is set to report an overview of the topline data from its lead multiple myeloma trial on September 6 and markets...
Do Hedge Funds Love Karyopharm Therapeutics Inc (KPTI)?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue...
Foresite Capital Management I Reveals 5.6% Position in Karyopharm Therapeutics
Foresite Capital Management I disclosed, in a new filing with the SEC, a new passive stake in Karyopharm Therapeutics Inc (NASDAQ:KPTI), which amasses...
